Search results
Results from the WOW.Com Content Network
Using cloned α 1 G, α 1 H, and α 1 I T-type calcium channels, Gomora's team found that ethosuximide blocked the channels with an IC 50 of 12 ± 2 mmol/L and that of N-desmethylmethsuximide (the active metabolite of mesuximide) is 1.95 ± 0.19 mmol/L for α 1 G, 1.82 ± 0.16 mmol/L for α 1 I, and 3.0 ± 0.3 mmol/L for α 1 H. It was ...
N-Ethyl-1,3-benzodioxolylpentanamine (EBDP; Ethyl-K; 3,4-methylenedioxy-N-ethyl-α-propylphenethylamine) is a psychoactive drug and member of the phenethylamine chemical class which acts as an entactogen, psychedelic, and stimulant. It is the N-ethyl analog of 1,3-benzodioxolylpentanamine (BDP; K). Ethyl-K was first synthesized by Alexander ...
N-Ethylpentylone (β-keto-ethylbenzodioxolylpentanamine, βk-ethyl-K, βk-EBDP, ephylone) is a substituted cathinone and stimulant drug which was developed in the 1960s. [ 2 ] [ 3 ] It has been reported as a novel designer drug in several countries including the United Kingdom, [ 4 ] South Africa, [ 5 ] New Zealand, [ 6 ] the United States, [ 7 ...
[3] [4] In terms of the latter property, it inhibits enzymes such as cholesterol side-chain cleavage enzyme (CYP11A1, P450scc) and aromatase (CYP19A1), thereby inhibiting the conversion of cholesterol into steroid hormones and blocking the production of androgens, estrogens, and glucocorticoids, among other endogenous steroids. [4]
1-Aminopentane is an organic compound with the formula CH 3 (CH 2) 4 NH 2. It is used as a solvent , as a raw material in the manufacture of a variety of other compounds, including dyes, emulsifiers , and pharmaceutical products, [ 1 ] and as a flavoring agent .
He came over, wished me good luck and let us skip the line. And as I made my way in, it really hit me: people were invested in what I was doing. On Oct. 29, I had my transhumeral amputation.
Pentamidine is an antimicrobial medication used to treat African trypanosomiasis, leishmaniasis, Balamuthia infections, [2] babesiosis, and to prevent and treat pneumocystis pneumonia (PCP) in people with poor immune function. [1]
Bristol-Myers Squibb provides a higher 4.3% yield and an acquisition-driven strategy to counter its 2028 patent cliff. Merck offers a lower but still attractive 3.25% yield, with its specialty ...